1. Vaccine in National Immunization Programme Update April 2016

2. Countries with Hib vaccine in the national immunization programme * Includes partial introduction Data source: WHO/IVB Database, as of 12 April 2016 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved. Introduced* to date (192 countries or 99%) Not Available, Not Introduced/No Plans (2 countries or 1%) Not applicable

3. Countries using IPV vaccine to date This information is available from the website @: IPV Introduction, OPV Withdrawal and Routine Immunization Strengthening: http://www.who.int/immunization/diseases/poliomyelitis/in activated_polio_vaccine/en/ IPV Introduction, OPV Withdrawal and Routine Immunization Strengthening http://www.who.int/immunization/diseases/poliomyelitis/in activated_polio_vaccine/en/ (click on the hyperlink to access the website – on its right hand column a slide set presentation in downloadable)

4. Countries with Pneumococcal Conjugate vaccine in the national immunization programme; and planned introductions in 2016 * Includes partial introduction Data source: WHO/IVB Database, as of 12 April 2016 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved. Introduced* to date (130 countries or 67%) Planned introductions in 2016(6 countries or 3.1%) Not Available, Not Introduced/No Plans (58 countries or 29.9%) Not applicable

5. Countries with Rotavirus vaccine in the national immunization programme; and planned introductions in 2016 * Includes partial introduction Data source: WHO/IVB Database, as of 12 April 2016 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved. Introduced* to date (85 countries or 43.8%) Planned introductions in 2016(6 countries or 3.1%) Not Available, Not Introduced/No Plans (103 countries or 53.1%) Not applicable

6. Countries with HPV vaccine in the national immunization programme * Includes partial introduction Data source: WHO/IVB Database, as of 12 April 2016 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved. Introduced* to date (66 countries or 34%) Not Available, Not Introduced/No Plans (128 countries or 66%) Not applicable

7. Countries using Measles Second Dose vaccine to date; and planned introductions in 2016 Data source: WHO/IVB Database, as of 12 April 2016 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved. Introduced to date (160 countries or 82.5%) Planned introductions in 2016(3 countries or 1.5%) Not Available, Not Introduced/No Plans (31 countries or 16%) Not applicable

8. Countries with Rubella vaccine in the national immunization programme; and planned introductions in 2016 Data source: WHO/IVB Database, as of 12 April 2016 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved. Introduced to date (148 countries or 76.3%) Planned introductions in 2016(11 countries or 5.7%) Not Available, Not Introduced/No Plans (35 countries or 18%) Not applicable

9. Countries with Hepatitis B Birth dose (HepB-BD) vaccine in the national immunization programme The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved. Data source: WHO/IVB Databse as at 12 April 2016 and ECDC published data at http://vaccine- schedule.ecdc.europa.eu/Pages/Scheduler.aspxhttp://vaccine- schedule.ecdc.europa.eu/Pages/Scheduler.aspx 194 WHO Member States Map production Immunization Vaccines and Biologicals (IVB), World Health Organization Date of slide: 12 April 2016 (98 countries or 51%) HepB-BD only for infants born to HBsAG-positive mothers (21 countries or 11%) HepB given only for risk groups or adolescents (4 countries or 2%) HepB in schedule but no HepB-BD Not available Not applicable (71 countries or 37%) HepB-BD introduced to date

10. Countries with Influenza vaccine in the national immunization programme Data source: WHO/IVB Database, as of 12 April 2016 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved. Introduced to date (103 countries or 53%) Not Available, Not Introduced/No Plans (89 countries or 46%) Not applicable Introduced in parts of the country (2 countries or 1%)

11. Countries and Territories using Yellow fever* vaccine to date * WHO considers that 44 countries/Territories are at risk for Yellow fever Data source: WHO/IVB Database, as of 12 April 2016 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved. Introduced to date(32 countries or 73%) Introduced in High risk areas(3 countries or 7%) At risk but not introduced(9 countries or 20%) Not Available / Not at risk Not applicable

12. Countries and Territories using JE vaccine to date Data source: WHO/IVB Database, as of 12 April 2016 International travel Health Database (http://www.who.int/wer/2013/wer8834.pdf?ua=1) Map production Immunization Vaccines and Biologicals (IVB), World Health Organization The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved. At risk countries/areas but not introduced (11 countries or 50%) Introduced to date(6 countries or 27%) Introduced in parts of the country (5 countries or 23%) Not applicable